Ocuphire Pharma Inc. Stock
Price
Target price
€1.41
€1.41
-8.240%
-0.128
-8.240%
€18.30
22.04.24 / Tradegate
WKN: A2QG4Z / Symbol: OCUP / Name: Ocuphire Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Ocuphire Pharma Inc. Stock
Heavy losses for Ocuphire Pharma Inc. today as the stock fell by -€0.128 (-8.240%).
Currently there is a rather positive sentiment for Ocuphire Pharma Inc. with 5 Buy predictions and 1 Sell predictions.
With a target price of 18 € there is potential for a 1172.98% increase which would mean more than doubling the current price of 1.41 € for Ocuphire Pharma Inc..
Our community identified positive and negative aspects for Ocuphire Pharma Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ocuphire Pharma Inc. stock. On the other hand our users think that "Innovation" could be a problem in the future.
Pros and Cons of Ocuphire Pharma Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ocuphire Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ocuphire Pharma Inc. | -8.240% | -13.780% | -26.963% | -70.785% | -49.410% | - | - |
| Immunic Inc. | 0.340% | 1.139% | -5.949% | -19.018% | -19.301% | -90.399% | - |
| NanoViricides Inc. | 0.990% | -3.774% | 0.990% | -10.526% | 7.937% | -70.605% | -77.232% |
| Synthetic Biologics Inc. | -1.570% | -18.616% | -26.509% | -47.538% | -14.750% | -92.354% | -93.180% |
Comments
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at Alliance Global Partners from $24.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $17.00 price target on the stock.
Show more
Ratings data for OCUP provided by MarketBeat